155 related articles for article (PubMed ID: 31257939)
41. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
[TBL] [Abstract][Full Text] [Related]
42. Exploring pharmacists' perceptions regarding influenza and streptococcal testing within a chain pharmacy.
Dulaney K; Hohmeier K; Fisher C; Cardosi L; Wasson M
J Am Pharm Assoc (2003); 2018; 58(4):438-441.e1. PubMed ID: 29691199
[TBL] [Abstract][Full Text] [Related]
43. Understanding pharmacists' experiences with advice-giving in the community pharmacy setting: a focus group study.
Simmons-Yon A; Roth MT; Vu M; Kavalieratos D; Weinberger M; Rao JK
Patient Educ Couns; 2012 Dec; 89(3):476-83. PubMed ID: 22995598
[TBL] [Abstract][Full Text] [Related]
44.
Byrne C; Radley A; Inglis SK; Beer LJZ; Palmer N; Pham MD; Healy B; Doyle JS; Donnan P; Dillon JF
BMJ Open; 2020 Aug; 10(8):e036501. PubMed ID: 32868356
[TBL] [Abstract][Full Text] [Related]
45. Addressing Barriers to HIV Point-of-Care Testing in Community Pharmacies.
McKeirnan K; Kherghehpoush S; Gladchuk A; Patterson S
Pharmacy (Basel); 2021 Apr; 9(2):. PubMed ID: 33923668
[TBL] [Abstract][Full Text] [Related]
46. Pharmacist-led HIV and hepatitis C point-of-care testing and risk mitigation counseling in individuals experiencing homelessness.
Kherghehpoush S; McKeirnan KC
Explor Res Clin Soc Pharm; 2021 Mar; 1():100007. PubMed ID: 35479505
[TBL] [Abstract][Full Text] [Related]
47. Pharmacist's Demand for Optimal Primary Care Service Delivery in a Community Pharmacy: The OPTiPharm Study.
Munger MA; Walsh M; Godin J; Feehan M
Ann Pharmacother; 2017 Dec; 51(12):1069-1076. PubMed ID: 28737045
[TBL] [Abstract][Full Text] [Related]
48. Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control.
Tucker JD; Bien CH; Peeling RW
Curr Opin Infect Dis; 2013 Feb; 26(1):73-9. PubMed ID: 23242343
[TBL] [Abstract][Full Text] [Related]
49. Pharmacist perceptions of the New Mexico pharmacist-performed tuberculosis testing program.
Logothetis SJ; Borrego ME; Roberts MH; Bachyrycz A; Timmins GS; Jakeman B
J Am Pharm Assoc (2003); 2018; 58(6):647-651. PubMed ID: 30274884
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
51. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
Blake KB; Madhavan SS
Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
[TBL] [Abstract][Full Text] [Related]
52. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
[TBL] [Abstract][Full Text] [Related]
53. Pharmacists' comfort level and knowledge about prescribing hormonal contraception in a supermarket chain pharmacy.
Lio I; Remines J; Nadpara PA; Goode JKR
J Am Pharm Assoc (2003); 2018; 58(4S):S89-S93. PubMed ID: 30006191
[TBL] [Abstract][Full Text] [Related]
54. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates.
Alzubaidi H; Saidawi W; Mc Namara K
Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256
[TBL] [Abstract][Full Text] [Related]
55. Patient awareness of specialized diabetes services provided in community pharmacies.
Mansell K; Perepelkin J
Res Social Adm Pharm; 2011 Dec; 7(4):396-405. PubMed ID: 21272537
[TBL] [Abstract][Full Text] [Related]
56. Influences on the frequency and type of community pharmacy services.
Doucette WR; Rippe JJ; Gaither CA; Kreling DH; Mott DA; Schommer JC
J Am Pharm Assoc (2003); 2017; 57(1):72-76.e1. PubMed ID: 27777075
[TBL] [Abstract][Full Text] [Related]
57. Community pharmacy-based point-of-care testing: A case study of pharmacist-physician collaborative working relationships.
Bacci JL; Klepser D; Tilley H; Smith JK; Klepser ME
Res Social Adm Pharm; 2018 Jan; 14(1):112-115. PubMed ID: 28082033
[TBL] [Abstract][Full Text] [Related]
58. Pharmacy personnel comfort and confidence in screening for social needs: A pilot study.
Kiles TM; Chen C; Leibold C; Cardosi L; Hill H; Hohmeier KC
J Am Pharm Assoc (2003); 2023; 63(4S):S83-S87. PubMed ID: 36863964
[TBL] [Abstract][Full Text] [Related]
59. Community pharmacist-directed point-of-care group A Streptococcus testing: Evaluation of a Canadian program.
Papastergiou J; Trieu CR; Saltmarche D; Diamantouros A
J Am Pharm Assoc (2003); 2018; 58(4):450-456. PubMed ID: 29681440
[TBL] [Abstract][Full Text] [Related]
60. Implementation of hepatitis C screening within a pharmacist-managed medication-assisted therapy opioid use disorder protocol program.
Llayton CK; Harlow CP; Burris JN; Rhodes J
J Am Pharm Assoc (2003); 2020; 60(6):e307-e311. PubMed ID: 32527703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
